RE FRANCESCA

Sierri, G., Saenz-De-Santa-Maria, I., Renda, A., Koch, M., Sommi, P., Anselmi-Tamburini, U., et al. (2025). Nanoparticle shape is the game-changer for blood-brain barrier crossing and delivery through tunneling nanotubes among glioblastoma cells. NANOSCALE, 17(2), 992-1006 [10.1039/d4nr03174a]. Detail

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Detail

Pagnacco, C., Kravicz, M., Sica, F., Fontanini, V., González de San Román, E., Lund, R., et al. (2024). In Vitro Biocompatibility and Endothelial Permeability of Branched Polyglycidols Generated by Ring-Opening Polymerization of Glycidol with B(C6F5)3 under Dry and Wet Conditions. BIOMACROMOLECULES, 25(6), 3583-3595 [10.1021/acs.biomac.4c00210]. Detail

Resnik, N., Levallet, G., Errede, M., Re, F., Virgintino, D. (2024). Editorial: Molecular profiles of tunneling nanotubes (TNTs) in human diseases-from 2D cultures to complex tissue. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 14(12) [10.3389/fcell.2024.1461453]. Detail

Shaik, M., Pasco, S., Romerio, A., Pifferi, C., Sesana, S., Re, F., et al. (2024). Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant. JOURNAL OF MEDICINAL CHEMISTRY, 67(24), 22254-22262 [10.1021/acs.jmedchem.4c02392]. Detail